Imaging-guided lumbar facet injections: is there a difference in outcomes between low back pain patients who remember to return a postal questionnaire and those who do not? by Kremer, Stefanie
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2013
Imaging-guided lumbar facet injections: is there a difference in outcomes
between low back pain patients who remember to return a postal
questionnaire and those who do not?
Kremer, Stefanie
Abstract: Unspecified
DOI: 10.1007/s13244-012-0178-8
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-78432
Originally published at:
Kremer, Stefanie. Imaging-guided lumbar facet injections: is there a difference in outcomes between
low back pain patients who remember to return a postal questionnaire and those who do not? 2013,
University of Zurich, Faculty of Medicine. DOI: 10.1007/s13244-012-0178-8
ORIGINAL ARTICLE
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Objectives To determine whether data obtained from
patients returning postal questionnaires accurately reflect
how patients receiving imaging-guided lumbar facet injec-
tions respond.
Methods Seventy-eight patients receiving lumbar facet
joint injections who returned an outcomes questionnaire
(responders) were age and gender matched with 78
patients who did not return the postal questionnaire
(non-responders) after facet joint injections. Baseline
numerical rating scale (NRS) pain data were collected.
NRS and Patients’ Global Impression of Change (PGIC)
data were collected 1 month after injection by postal
questionnaire or telephone interview.
Differences in NRS scores were calculated using the
unpaired t-test. One level injection patients were compared
to patients having ≥2 levels injected using the paired and
unpaired t-test. The proportion of patients reporting signif-
icant improvement in each group was calculated.
Results NRS scores were significantly improved compared
to baseline (p00.0001). Thirty-eight percent of responders
were significantly improved compared to 50 % of non-
responders. Patients having ≥2 levels injected reported
there was no difference in NRS scores between groups.
Conclusions Patients returning postal questionnaires report a
less favourable outcome. Telephone interview patients having
injections at more than one level have better outcomes.
Main messages
• Patients returning postal questionnaires report worse out-
comes after facet injection.
• Method of data collection should be considered when
reporting treatment outcomes.
• Patients receiving facet injections at more than one level
report greater levels of pain reduction.
Keywords Low back pain . Facet joint pain . Lumbar facet
joint . Lumbar intra-articular steroid injection . Outcomes
Introduction
Lumbar facet joints are considered to be a common source
of chronic low back pain [1–12]. Golthwait is credited as the
first to describe pain originating from the facet joints in 1911
as cited by van Kleef et al. [1], while Ghormley first coined
the term “facet syndrome” in 1933 (as cited by van Kleef et
al.) [1]. Manchikanti et al. [2] demonstrated that the facet
joint is a source of pain in a significant number of patients
suffering from chronic low back pain, with further research
support for the existence of facet joint pain coming from
Berven et al. [3]. Although the presence of a “facet syn-
drome” has long been questioned, it is now generally ac-
cepted as a clinical entity [1]. In accordance with criteria
established by the International Association for the Study of
Pain, the facet joints have been shown to be the source of
chronic low back pain in 15 % to 45 % of patients [4].
S. Kremer : C. W. A. Pfirrmann :C. K. Peterson (*)
Department of Radiology, Orthopaedic University
Hospital of Balgrist,
Forchstrasse 340,
8008 Zürich, Switzerland
e-mail: cynthia.peterson@balgrist.ch
J. Hodler
Department of Radiology, University Hospital,
Rämistrasse 100,
8091 Zürich, Switzerland
Insights Imaging (2012) 3:411–418
DOI 10.1007/s13244-012-0178-8
# The Author(s) 2012. This article is published with open access at Springerlink.com
Abstract significantly higher baseline NRS scores, but by 1 month
Unfortunately, it is not always possible to pinpoint the exact
structure or pathology responsible for LBP, because no physical
examination findings are pathognomonic for the diagnosis of
low back pain of facet origin. Controlled, comparative anes-
thetic blocks of the lumbar medial branches have been stated to
be the most reliable method of diagnosing facet-mediated pain
[5]. However, VanKleef et al. [1] found that bothmedial branch
and intra-articular blocks can be used equally for diagnosis and
mentioned that there is no gold standard for diagnosing low
back complaints originating from the facet joints.
The treatment of facet pain is also the subject of great
controversy. Lumbar facet joint interventions, such as
image-guided intraarticular injections, may be used to manage
chronic facet-mediated low back pain [6–9]. For carefully
selected cases, lumbar facet block is a relatively simple, safe
and minimally invasive procedure that can be a valuable
adjunct in the treatment [6]. Boswell et al. [7] conclude in
their review article that the evidence for lumbar intraarticular
facet joint injections for short- and long-term pain relief is
moderate for lumbar pain. A more recent systemic review in
2010 [9] also stated that there is moderate to strong evidence
supporting the use of injections into the facet joints. Some
controversy has been reported for the value of these intraar-
ticular injections in the facet joints in other studies, however.
Datta et al. [10] concluded that although there is strong evi-
dence for the diagnostic accuracy of facet joint blocks in
evaluating spinal pain, the evidence for therapeutic lumbar
intraarticular injections is level III (limited). Furthermore, an
earlier study [11] found that intra-articular facet joint injec-
tions containing corticosteroids seemed to have no additional
therapeutic effect on lower back pain compared to injections
of anesthetic alone. It has even been suggested that intra-
articular facet joint injections may be no better than placebo
for chronic lumbar spine pain [12]. In spite of this conflicting
evidence, these injections are commonly used to either diag-
nose or treat patients with chronic low back pain.
The quality of clinical research depends to a large degree
on the validity of data obtained directly from patients.
Edwards et al. [13] stated in their systematic review that the
response rate of collecting valuable data can be increased by
using a shorter questionnaire. Non-response to questionnaires
reduces the effective sample size and can introduce bias. Since
only half or less than half of patients remember to return
questionnaires, it is plausible to ask whether those returned
questionnaires truly represent the outcomes from a given
procedure. The outcomes comparing questionnaire non-
responders to questionnaire responders may give a better idea
as to the overall effectiveness of an intervention or procedure.
Johansen and Wedderkopp [14] reported that retrospective
data can safely be collected for up to 1 month. Beyond that
time span, recall becomes imprecise. Another study from
Bolton and Humphreys [15] also demonstrated that rating of
pain by patients with the Numerical Rating Pain Scale (NRS)
provides accurate and reliable information for clinical evalu-
ation and that patients are able to accurately recall their pain
retrospectively.
Hundreds of image-guided lumbar facet joint injections
are performed every year at our orthopaedic university hos-
pital in Zürich, Switzerland. As part of the quality control
evaluation, all patients are handed a short outcomes-based
questionnaire collecting pain and quality-of-life data to be
returned after 1 month. However, because less than 50 % of
patients return these questionnaires and because the out-
comes from the patients who do return their question-
naires appeared to be worse than the figures reported in
the literature, it was desired to do a comparison of the
outcomes from patients who return these questionnaires
with those who do not. This is needed to determine if
the data from returned questionnaires are an accurate
reflection of the true outcomes of patients receiving these
lumbar facet joint injections. The purpose of this study
was to address this issue.
Materials and methods
Consecutive patients referred for imaging-guided lumbar
facet injections between 5 September 2010 and 22 Jan-
uary 2011 were included in the study. Hospital and
regional ethics approval was obtained for all imaging-
guided injections and follow-up questionnaire data col-
lection. All patients signed informed consent. A total of
210 patients received these infiltrations, and all were
given a postal questionnaire along with a stamped and
addressed envelope with instructions to return this com-
pleted questionnaire after 1 month. Baseline pain data
using the numerical rating scale (NRS, where 0 is no
pain and 10 is the worst pain imaginable) were collect-
ed on all patients prior to injection as well as at 20–
30 min after injection before they left the radiology
department. Because only approximately 50 % of the
patients returned these 1-month questionnaires, their
outcomes were compared to the outcomes of patients
who did not return their questionnaires (non-responders)
as collected by telephone interview.
Facet injection procedure
Under sterile conditions (3× disinfection, sterile gloves,
mask, sterile covering), fluoroscopy-guided puncture of the
relevant facet joint/s was performed. Documentation of the
needle position was done with contrast medium and fluo-
roscopy. Injection of 40 mg Kenacort (triamcinolone aceto-
nide; Dermapharm AG, Huenenberg AG, Switzerland) and
1 ml ropivacaine (Naropin; Astra-Zeneca, Södertälje, Swe-
den) was then performed (Fig. 1).
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Outcomes
Baseline and 1-month data were collected for both postal
responders and non-responders. For the patients who
returned their questionnaire, this data consisted of the
patient’s global impression of change (PGIC) assessed at
1 day, 1 week and 1 month after injection of anesthetic plus
corticosteroid. It also evaluated the pain response (NRS)
1 day, 1 week and 1 month after injection. The PGIC
consists of a 7-point scale anchored to statements about
change in the condition from 1 (much better) to 7 (much
worse). Only numbers 1 and 2 (much better or better)
counted as improvement. ‘Slightly better’ did not count as
improvement. A study from Newell et al. [16] showed that
change scores in outcome measures correlated with the
patient's perception of global improvement (PGIC). They
found that the PGIC can be used as a gold standard in
categorising patients as improved (or not).
For those patients who did not return their questionnaire
(non-responders), only the 1-month PGIC and NRS data
were collected by telephone interview no longer than 1 week
after the 1-month date for returning the postal question-
naires. The first author checked the imaging database regu-
larly to monitor which patients returned questionnaires and
which did not in order to time the telephone calls to the non-
responders as close to 1 month after injection as possible.
Thus the maximum time that the non-responders had to
retrospectively recall their 1-month pain and functional sta-
tus was 1 week. Therefore, this is a prospective outcomes
study on the cohort of patients who returned their question-
naire but a retrospective study using recall of the 1-month
data on the same outcomes for the cohort who did not return
their postal questionnaire.
Patients who did not return their questionnaires (non-
responders) were then age and gender matched
(±2 years) to patients who did return their question-
naires (responders). This resulted in 78 patients in each
group. Age and gender matching was done blinded to
any clinical outcomes.
Statistical analysis
Data from responders and non-responders were entered
into SPSS version 17.0 for analysis. Data were analysed
before and after age and gender matching. Age and
gender matching was performed because a higher pro-
portion of female patients remembered to return their
postal questionnaires. Descriptive statistics were calcu-
lated for patient ages, gender distribution, proportion of
patients returning their questionnaires and the proportion
of patients having only one spinal level injected com-
pared to more than one spinal level injected. The deci-
sion to compare patients with one level injected to those
with more than one level injected was made based on
the literature stating the difficulties in isolating specific
structures as the source of low back pain [5, 12] as well
as the fact that this was not done in previous studies.
Comparisons of the 20–30-min and 1-month NRS
scores to the baseline NRS scores were done for both
the responders and non-responders combined using the
paired Student’s t-test. Gender differences were evaluat-
ed for age, the baseline, 20–30-min and 1-month NRS
scores using the unpaired t-test.
Differences in NRS scores between the responders and
non-responders before and after age and gender matching
were calculated using the unpaired t-test. Comparisons of
the 20–30-min and 1-month NRS scores to the baseline
NRS score were done for each group separately using the
paired t-test. Additionally, the proportion of patients
responding favorably or unfavorably (PGIC scores) was
calculated for each group. Outcomes from patients having
only one level injected were compared to those of patients
having two or more levels injected using both the paired and
unpaired Student’s t-test to evaluate differences within and
between groups. Significance was set at p<0.05.
Results
Between the dates of 5 September 2010 and 22 January
2011, 210 patients received imaging-guided lumbar facet
joint infiltrations. Of these, 45 % of the patients were male
and 55 % were female. Only 107 patients returned their
postal outcomes questionnaire (responders) (51 %). From
the subgroup of non-responders (103 patients), 82.5 % (85
patients) could be reached by telephone, and their 1-month
outcome data were collected. Age (±2 years) and gender
matching was accomplished for 156 patients (78 responders
and 78 non-responders).
Forty-seven percent of all combined (postal responder
and non-responder) patients had one level injected com-
pared to 53 % who had two or more levels injected. All
patients were treated with therapeutic injections (anesthetic
Fig. 1 L4-5 bilateral facet injections. Arrowheads show the contrast
within the joint capsules. Curved arrow shows the tip of the needle
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plus corticosteroid). Only one patient called by telephone
mentioned a mild adverse reaction (headache).
The mean age of all patients (postal responders and non-
responders) was 63.3 years (SD 12.6), with the youngest
patient being 23 years old and the oldest patient being
90 years old. There was a significant age difference (p0
0.04) between males and females in the subgroup of the
patients who did return their questionnaires. The mean age
of the women was 60.8 (SD 13.2) and of the men 64.3 (SD
12.0). In the subgroup of the non-responders there was no
significant age difference between females and males.
The baseline NRS pain scores, the 20-30-min NRS scores
and the 1-month NRS scores showed no significant gender
differences between the responder and the non-responder-
groups. The mean NRS baseline pain score of all patients
was 7.0 (SD 2.2), the mean NRS score after 20-30 min was
4.0 (SD 2.6) and the NRS score at 1 month after treatment
was 4.7 (SD 2.7). The 20-30-min and 1-month NRS scores
were statistically significantly improved compared to the
baseline score (p00.0001) (Table 1).
The results from the Patient’s Global Impression of Change
(PGIC) scores prior to age and gender matching indicate that
patients who did not return their questionnaires seem to have
better outcomes after facet joint injections compared to
patients who did return their questionnaires. Of the patient
group of responders (questionnaire returned), 33 % were
clinically significantly improved at 1 month compared to
49 % of the patients who did not return their postal question-
naire (telephone interviews). Furthermore, 15 % of the
patients who did return their postal questionnaire stated that
they were worse at 1 month (8 % slightly worse, 5 % worse
and 2 % much worse). Only 4 % of the telephone interview
patients reported that they were slightly worse, with none of
the patients stating that they were worse or much worse
(Table 2). This was significantly different at p00.02. The
remainder of patients reported being unchanged.
Comparing patients with one level injected to those hav-
ing more than one spinal level injected when both respond-
ers and non-responders were analysed together showed that
patients having more than one level injected had higher
baseline NRS scores. However, when analysing the two
groups separately, this was only statistically significantly
different in the telephone interview patients (p00.012)
(Table 3), whereas it did not reach statistical significance
in the responders (postal questionnaire) group (Table 4). The
telephone interview patients (non-responders) who had
more than one level injected also had significantly higher
NRS scores at 20-30 min compared to those patients having
only 1 level injected (p00.04), but by 1 month there was no
significant difference between the two groups. Therefore,
particularly non-responder patients having more than one
level injected tended to present with higher pain levels, but
by 1 month there was no difference compared to patients
having only one level injected.
Age- and gender-matched comparisons
In both patient groups (postal responders and non-
responders) the 20-30-min NRS scores and the 1-month
NRS scores were statistically significantly improved com-
pared to the baseline score (p00.0001). Comparing the
baseline NRS scores, the 20-30-min NRS scores and the
1-month NRS scores between the postal patients and the
telephone patients showed that the telephone patients had a
significantly higher mean 1-month NRS score (p00.008)
(Table 5)
The PGIC results obtained by age and gender matching
of the patients reflect the outcomes calculated from the
population that was not age and gender matched. Patients
who did not return their questionnaires also reported better
outcomes after facet joint injections than patients who did
return their questionnaires. Of the patient group of respond-
ers (questionnaire returned), 38 % were clinically signifi-
cantly improved at 1 month compared to 50 % of the
patients who did not return their postal questionnaire (tele-
phone interviews). Furthermore, 14 % of the patients who
did return their postal questionnaire stated that they were
worse at 1 month (6 % slightly worse, 5 % worse and 3 %
much worse). Only 4 % of the telephone interview patients
reported that they were slightly worse, with none of the
patients stating that they were worse or much worse
(Table 6). This was statistically significant at p00.02.
Comparing the age- and gender-matched patients who
had only one level injected to those having more than one
spinal level injected for the responders and non-responders
together showed that patients having two or more spinal
levels injected reported significantly higher mean baseline
NRS scores (7.6, SD 0 2.2) compared to those having only
one level injected (6.5, SD 0 2.3, p00.005). This difference
remained statistically significantly higher in the multiple
injection level group when looking at the telephone inter-
view patients alone (p00.03) (Table 7). However, it did not
reach statistical significance in the responder (postal ques-
tionnaire) group (Table 8). The telephone interview patients
(non-responders) who had more than one level injected still
had higher NRS scores at 20-30 min compared to those
patients having only one level injected (p00.053), but this
Table 1 NRS results for all patients up to 1 month after injection
Baseline data and outcomes Mean + (SD)
Pre NRS (baseline) 7.0 (2.2)
20-30-min NRS 4.0 (2.6)*
1-month NRS 4.7 (2.7)*
*p00.0001 compared to the baseline score
414 Insights Imaging (2012) 3:411–418
did not quite reach statistical significance. At 1 month
there was no significant difference between the two
groups. Therefore the trend is for patients having two
or more levels injected to present with more pain, but
by 1 month post injection to have improved such that
there is no difference in pain level compared to patients
having only one level injected.
Discussion
The purpose of this study was to determine whether or not
the outcome data obtained from patients returning postal
questionnaires are an accurate reflection of how patients
receiving image-guided lumbar facet injections respond.
At least at this orthopaedic university hospital patients
who return their outcomes postal questionnaires report that
they are less likely to experience clinically relevant im-
provement and significantly more likely to be worse 1 month
after lumbar facet injections compared to patients who for-
got to return their postal questionnaires but were inter-
viewed via telephone. Therefore, relying only on the data
obtained from the postal questionnaires gives a less favour-
able impression of the outcomes from this intervention. This
is not too surprising as it is logical that patients who are still
suffering or particularly those who are worse after injection
desire to provide feedback. Indeed, several of the envelopes
containing the returned postal questionnaires also included
hand-written letters with specific details about the patient’s
pain and suffering.
This current study supports the findings from previous
research in that patients receiving lumbar intra-articular
facet joint injections reported significantly reduced mean
low back pain NRS scores [6–9] and many patients also
reported clinically significant overall improvement (PGIC).
The mean NRS scores of both postal responder and non-
responder patients at 20-30 min and 1 month after injection
were statistically significantly improved compared to their
mean baseline scores.
Interestingly, in the age- and gender-matched population,
those patients who received the telephone interview (i.e. did
not return their questionnaire) had a significantly higher
mean 1-month NRS score compared to the patients return-
ing their postal questionnaire, yet 50 % of the telephone
interview patients reported according to their PGIC score
that they were clinically significantly improved compared to
only 38 % of the postal (responders) patients. The NRS
score only covers the pain intensity of low back pain,
whereas the PGIC also contains psychological domains that
may be influential, especially in chronic conditions. Newell
and Bolton [16] showed that even at 4 weeks psychosocial
Table 2 PGIC results for postal patients (responders) and telephone
patients (non-responders)
Baseline data and outcomes Responders
(postal)
Non-responders
(telephone)
PGIC improved (1 and 2) 33 % 49 %
PGIC worse
(5, 6 and 7)
15 % 4 % p00.02
Slightly worse (5) 8 % 4 %
Worse (6) 5 % 0 %
Much worse (7) 2 % 0 %
Table 3 NRS score results of patients with one level injected com-
pared to those having two or more levels injected within the group of
non-responders (telephone patients)
Baseline
data and
outcomes
1 level
injected,
mean + (SD)
2 or more levels
injected, mean +
(SD)
1 vs. 2 level
statistical
significance (p)
Pre NRS
(baseline)
6.5+(2.4) 7.9+(2.2) 0.012 **
20-30-min
NRS
3.5+(2.7)* 4.8+(2.7)* 0.04**
1-month
NRS
5.3+(3.0)* 5.3+(2.5)* 0.924
*p<0.05 compared to baseline scores, **p<0.05 compared to each
other
Table 4 NRS score results of patients with one level injected com-
pared to those having two or more spinal levels injected within the
group of responders (postal questionnaire)
Baseline
data and
outcomes
1 level
injected,
mean + (SD)
2 or more levels
injected, mean +
(SD)
1 vs. 2 level
statistical
significance (p)
Pre NRS
(baseline)
6.8+(2.1) 7.0+(2.0) 0.666
20-30-min
NRS
3.8+(2.5)* 4.0+(2.7)* 0.524
1-month
NRS
4.6+(2.7)* 4.4+(2.6)* 0.682
*p<0.05 compared to baseline score
Table 5 NRS results for the age- and gender-matched postal patients
(responders) and the telephone patients (non-responders)
Baseline
data and
outcomes
Responders
(postal),
mean + (SD)
Non-responders
(telephone),
mean + (SD)
Responders vs.
non-responders,
statistical signifi-
cance (p)
Pre NRS
(baseline)
6.8 (2.1) 7.2 (2.4) 0.223
20-30-min
NRS
3.7 (2.6)* 4.3 (2.8)* 0.195
1-month
NRS
4.2 (2.6)* 5.3 (2.7)* 0.008**
*p00.0001 compared to baseline score
**p00.008 compared to each other
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components are already exerting significant effects on the
success of treatment. Thus, the PGIC is considered more of
a gold standard in categorising patients as improved or not.
Patients having more than one lumbar facet level injected
started with significantly higher mean pain scores compared
to patients having only one level injected. However, at
1 month there was no significant difference between the
two groups in their mean NRS scores. This was particularly
true for the non-responder group. Thus patients who had
injections at more than one spinal level seemed to obtain a
greater magnitude of pain reduction. A potential reason for
this is the difficulty in identifying one specific generator of
low back pain, particularly for diagnosing the facet
joints as a source of low back pain. There is no radio-
graphic finding, characteristic physical examination or
specific clinical symptom that proves lumbar facet-
mediated pain with certainty [1, 3]. The radiographic
severity of facet disease is also not associated with pain
severity among those with chronic low back pain [17].
Even magnetic resonance imaging scans of the lumbar
spine are unable to predict the development of low-back
pain [18]. Therefore, injecting at more levels provides a
higher chance of targeting the suspected painful facet
joints, particularly in those patients whose pain arises
from more than one facet articulation. Although both
groups were age and gender matched, this difference in
the mean baseline NRS scores between the two groups
clearly shows that they were not matched for all factors.
The validity of any outcome data however depends to a
large degree on the ability of patients to accurately recall their
pain levels, disability and other quality-of-life measures. This
is especially important when the recall of pain intensity is
done retrospectively. It has been shown from different studies
that patients are able to fairly accurately recall and rate an
average of their pain intensity across a number of lengths of
time, from 24 h [19] to 1 week [15] even up to 1 month [14].
Thus, it is likely that the outcome data from the patients
receiving telephone calls in this study accurately reflect the
pain severity and overall feeling experienced by these patients
during the inquiry time period. This is particularly true as the
1-month telephone calls, although retrospective data collec-
tion, occurred no longer than 1 week after the 1-month ques-
tionnaire was due. This is well within the time period for
accurate recall of data [14, 15].
Another important influence on the accuracy/validity of
outcome data is the form of data collection used. Several
methods exist for collecting data, including hard copy ques-
tionnaires, on-line questionnaires (including text messag-
ing), face-to-face interviews and telephone interviews. The
findings of different studies imply that a mode-of-
administration effect exists [20–22]. The interest and under-
standing of a live interviewer may encourage more positive
responses, while the anonymity provided by mail surveys
may lead to more accurate reports [22]. In general, it is
advisable to take the mode of data collection into account
when selecting values for comparison. Researchers should
consider this when comparing results from similar studies
that use different methods for collecting the data [20–22].
As noted above, patients who were interviewed by tele-
phone reported better overall 1-month outcomes (PGIC)
after facet joint injections compared to patients who did
return their questionnaires and were also much less likely
to report that they were worse after injection. The effect of
the method of administration or type of data collection
therefore may have influenced these results (i.e. postal
Table 6 PGIC results for age- and gender-matched postal patients
(responders) and telephone patients (non-responders)
Baseline data and outcomes Responders
(postal)
Non-responders
(telephone)
PGIC improved (1 and 2) 38 % 50 %
PGIC worse (5, 6 and 7) 14 % 4 % P00.02
Slightly worse (5) 6 % 4 %
Worse (6) 5 % 0 %
Much worse (7) 3 % 0 %
Table 7 NRS score results of age- and gender-matched patients with
one level injected compared to those having more than one spinal level
injected within the group of non-responders (telephone patients)
Baseline data
and outcomes
1 level injected,
mean + (SD)
2 or more levels
injected, mean +
(SD)
1 vs. > 2
levels (p)
Pre NRS
(baseline)
6.5+(2.5) 7.8+(2.3) 0.03
20-30-min
NRS
3.5+(2.9)* 4.8+(2.7)* 0.053
1-month NRS 5.4+(3.1)* 5.2+(2.5)* 0.765
*p<0.05 compared to the baseline score
Table 8 NRS score results of age- and gender-matched patients with
one level injected compared to those having more than one spinal level
injected within the group of responders (postal questionnaire)
Baseline data
and outcomes
1 level
injected,
mean + (SD)
2 or more
levels injected,
mean + (SD)
1 vs. > 2
levels (p)
Pre NRS
(baseline)
6.5 (2.1) 7.2 (2.1) 0.144
20-30-min NRS 3.7 (2.6)* 3.8 (2.6)* 0.991
1-month NRS 4.4 (2.5)* 3.9 (2.7)* 0.371
*p<0.05 compared to baseline scores
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questionnaire vs. telephone interview) [20–22]. These dif-
ferences between postal patients (responders) and telephone
interview patients (non-responders) are consistent with pre-
vious research in which telephone administration yielded
more positive reports than self-administration [20–22].
However, the fact that the telephone interview patients in
this current study had higher 1-month NRS pain scores
compared to those who returned their questionnaire, thus
reporting higher pain levels, suggests that these telephone
data are likely to be reliable and valid. Interview adminis-
tration (by telephone) also yields higher participation rates
(82.5 % could be reached) than administration by question-
naires (only 51 % returned their completed questionnaire). It
was particularly noticed during the telephone interview that
many of the patients who did not return their questionnaires
were often foreign nationals and therefore may not have had
sufficient German reading and comprehension skills to com-
plete the questionnaire. This could also be a reason for non-
response.
The main limitation of this study is also related to the
main purpose of the study, to determine if outcomes from
lumbar facet injection depend on the method of data collec-
tion. During the telephone interview, the patients might have
a tendency to try and please or impress the interviewer, and
therefore may have been reluctant to be totally honest. Most
of the patients called by telephone were positively surprised
at receiving the telephone call from the hospital inquiring
about their response to the injections. Therefore, many
patients were in a positive mood while they were answering
the questions, which could have boosted their answers.
However, the fact that the mean NRS pain scale results for
the telephone patients demonstrated higher pain levels after
1 month compared to the postal patients suggests that the
results obtained in this study, at least for the NRS data, are
likely accurate [15].
Another limitation to this study is the relatively short
follow-up data collection time period of 1 month. However,
it is common for patients at this specialised orthopaedic/
rheumatology hospital to present for subsequent injections
and it was desired that the patients included in this study had
only one injection during the data collection period so that
more accurate comparisons between postal questionnaire
and telephone interview methods of data collection could
occur. Perhaps the true outcomes from lumbar facet injec-
tions lie somewhere between the poorer results reported by
those returning questionnaires and the better results from
patients reporting by telephone.
Conclusion
In conclusion, the findings of this study showed that patients
who did not return their questionnaires (and thus were
interviewed by telephone) reported clinically significantly
better overall outcomes after lumbar facet joint injections
compared to patients who did return their questionnaires.
Therefore, relying only on the results of patients returning
the postal questionnaire would have given a less favourable
impression of the outcomes from these injections. Patients
who had injections at more than one spinal level, particular-
ly those who did not remember to return their questionnaire,
seemed to obtain greater improvement in pain reduction.
These results may be relevant to other research in which
outcomes are assessed using questionnaires.
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